Efficacy of bupropion alone and in combination with nicotine gum

Citations of this article
Mendeley users who have this article in their library.
Get full text


In this double-blind, placebo-controlled smoking cessation treatment study, 608 participants were randomly assigned to receive active bupropion and active 4-mg gum (AA, n=228), active bupropion and placebo gum (AP, n=224), or placebo bupropion and placebo gum (PP, n=156). Relative to the PP group, the AA and AP groups were each significantly more likely to be abstinent at 1 week, end of treatment, and 6 months but not at 12 months postquit. After the first week postquit there were no differences in abstinence rates between the AA and AP groups. We found no significant individual difference variables that moderated outcome beyond 1 week postquit.




Piper, M. E., Federman, E. B., McCarthy, D. E., Bolt, D. M., Smith, S. S., Fiore, M. C., & Baker, T. B. (2007). Efficacy of bupropion alone and in combination with nicotine gum. Nicotine and Tobacco Research, 9(9), 947–954. https://doi.org/10.1080/14622200701540820

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free